Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Regulation of MMP‐9 expression and activity in the mouse uterus by estrogen

Regulation of MMP‐9 expression and activity in the mouse uterus by estrogen Matrix metalloproteinases (MMPs) are spatiotemporally expressed in the uterus across normal estrous and menstrual cycles and are known to participate in the extensive endometrial tissue remodeling. MMP‐9/gelatinase B is one of the major MMPs found in the uterus that modulates uterine biology during various reproductive processes. Although it seems that uterine MMP‐9 is under ovarian steroid hormonal control, there are conflicting reports regarding steroidal hormonal regulation of MMP‐9 expression, and there is little information on the effects of estrogen in vivo in this respect. We therefore examined the steroidal regulation of MMP‐9 within the mouse uterus. Female mice (2–3 months old) were ovariectomized and treated with estradiol‐l7β (E2) or E2 + progesterone (P4) and uterine gelatinase activity and expression were determined. Gelatin zymography revealed that E2 alone or in combination with P4 increased MMP‐9 activation, whereas Northern analysis showed that E2 decreased MMP‐9 steady state mRNA expression and an estrogen receptor antagonist ICI‐182, 780 blocked this effect. In contrast, uterine MMP‐2 expression and activity were not affected by steroidal treatments. Pretreatment with a transcription inhibitor actinomycin D or translation inhibitor cycloheximide indicates that E2 regulates uterine MMP‐9 at multiple points, involving transcriptional and posttranscriptional control as well as modulation of inhibitor activities. Collectively, these data suggest that E2 regulates uterine MMP‐9 expression and activity in vivo via a complex mechanism. This estrogen regulation of MMP‐9 activity may play an important role in uterine tissue remodeling. Mol. Reprod. Dev. © 2006 Wiley‐Liss, Inc. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular Reproduction & Development Wiley

Regulation of MMP‐9 expression and activity in the mouse uterus by estrogen

Loading next page...
1
 
/lp/wiley/regulation-of-mmp-9-expression-and-activity-in-the-mouse-uterus-by-lndIscN0Lu

References (34)

Publisher
Wiley
Copyright
Copyright © 2007 Wiley‐Liss, Inc., A Wiley Company
ISSN
1040-452X
eISSN
1098-2795
DOI
10.1002/mrd.20582
pmid
16967517
Publisher site
See Article on Publisher Site

Abstract

Matrix metalloproteinases (MMPs) are spatiotemporally expressed in the uterus across normal estrous and menstrual cycles and are known to participate in the extensive endometrial tissue remodeling. MMP‐9/gelatinase B is one of the major MMPs found in the uterus that modulates uterine biology during various reproductive processes. Although it seems that uterine MMP‐9 is under ovarian steroid hormonal control, there are conflicting reports regarding steroidal hormonal regulation of MMP‐9 expression, and there is little information on the effects of estrogen in vivo in this respect. We therefore examined the steroidal regulation of MMP‐9 within the mouse uterus. Female mice (2–3 months old) were ovariectomized and treated with estradiol‐l7β (E2) or E2 + progesterone (P4) and uterine gelatinase activity and expression were determined. Gelatin zymography revealed that E2 alone or in combination with P4 increased MMP‐9 activation, whereas Northern analysis showed that E2 decreased MMP‐9 steady state mRNA expression and an estrogen receptor antagonist ICI‐182, 780 blocked this effect. In contrast, uterine MMP‐2 expression and activity were not affected by steroidal treatments. Pretreatment with a transcription inhibitor actinomycin D or translation inhibitor cycloheximide indicates that E2 regulates uterine MMP‐9 at multiple points, involving transcriptional and posttranscriptional control as well as modulation of inhibitor activities. Collectively, these data suggest that E2 regulates uterine MMP‐9 expression and activity in vivo via a complex mechanism. This estrogen regulation of MMP‐9 activity may play an important role in uterine tissue remodeling. Mol. Reprod. Dev. © 2006 Wiley‐Liss, Inc.

Journal

Molecular Reproduction & DevelopmentWiley

Published: Mar 1, 2007

Keywords: uterus; 17‐beta‐estradiol; progesterone; MMP‐9

There are no references for this article.